Last $1.34 PHP
Change Today 0.00 / 0.00%
Volume 21.0K
As of 2:20 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

euro-med laboratories phil (EURO) Snapshot

Open
$1.34
Previous Close
$1.34
Day High
$1.34
Day Low
$1.34
52 Week High
04/14/14 - $2.50
52 Week Low
12/16/14 - $1.06
Market Cap
5.5B
Average Volume 10 Days
31.2K
EPS TTM
$0.05
Shares Outstanding
4.1B
EX-Date
06/16/14
P/E TM
27.8x
Dividend
$0.05
Dividend Yield
3.73%
Current Stock Chart for EURO-MED LABORATORIES PHIL (EURO)

Related News

No related news articles were found.

euro-med laboratories phil (EURO) Related Businessweek News

No Related Businessweek News Found

euro-med laboratories phil (EURO) Details

Euro-Med Laboratories Phil., Inc. manufactures and sells large and small volume parenterals and other solutions in the Philippines. The company operates through Manufacturing, Service, and Food Service segments. It offers parenteral products in glass and plastic containers. The company also manufactures sterile water for injection; intravenous fluids and special fluids; tablets and syrups/suspensions; antiseptic, feminine wash, cleansing, gargle, and vaginal solutions; products for nebulization and injection; intravenous sets; and other solutions, such as ophthalmic, inhalation, irrigation, and dialysis. In addition, it is involved in the operation of a dialysis center; distribution of venipuncture sets, IV administration sets, and IV equipment, as well as Limulus Amebocyte Lysate test kits; manufacture of purified and distilled drinking water; and toll manufacturing of pharmaceuticals. Further, the company is engaged in the operation of restaurants and bakeries, as well as provides food services, catering, food production, and related services. Euro-Med Laboratories Phil., Inc. exports its pharmaceutical products internationally. The company was incorporated in 1988 and is based in Manila, the Philippines. Euro-Med Laboratories Phil., Inc. operates as a subsidiary of U.S Automotive, Inc.

1,492 Employees
Last Reported Date: 05/21/14
Founded in 1988

euro-med laboratories phil (EURO) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

euro-med laboratories phil (EURO) Key Developments

Euro-Med Laboratories Philippines Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

Euro-Med Laboratories Philippines Inc. announced earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported operating revenue of PHP 264,578,630 against PHP 240,681,388 a year ago. Net income before tax was PHP 49,967,836 against PHP 51,513,685 a year ago. Net income attributable to parent equity holder was PHP 34,977,485 or PHP 0.01 diluted per share against PHP 36,059,579 or PHP 0.01 diluted per share a year ago. For the nine months, the company reported operating revenue of PHP 775,378,585 against PHP 721,845,864 a year ago. Net income before tax was PHP 121,689,026 against PHP 118,849,657 a year ago. Net income attributable to parent equity holder was PHP 85,182,318 or PHP 0.02 diluted per share against PHP 83,194,760 or PHP 0.02 diluted per share a year ago. As on date, book value per share was PHP 1.17 against PHP 1.2 per share as on December 31, 2013.

Euro-Med Laboratories Philippines Inc. Announces Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

Euro-Med Laboratories Philippines Inc. announced earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company's net sales were PHP 712.9 million compared with PHP 705.3 million a year ago. Operating income was PHP 82.3 million compared with PHP 76.5 million a year ago. Income before income tax was PHP 38.95 million compared with PHP 40.1 million a year ago. Net income was PHP 27.3 million or PHP 0.01 per basic and diluted share compared with PHP 28.2 million or PHP 0.01 per basic and diluted share a year ago. For the six months, the company's net sales were PHP 1,436.0 million compared with PHP 1,349.3 million a year ago. Operating income was PHP 149.8 million compared with PHP 141.4 million a year ago. Income before income tax was PHP 71.7 million compared with PHP 67.3 million a year ago. Net income was PHP 50.2 million or PHP 0.01 per basic and diluted share compared with PHP 47.1 million or PHP 0.01 per basic and diluted share a year ago. Net cash provided by operating activities was PHP 451.3 million compared with PHP 130.6 million a year ago. Acquisition of property, plant and equipment was PHP 30.0 million compared with PHP 70.2 million a year ago.

Euro-Med Laboratories Phil., Inc. Declares Cash Dividend, Payable on July 11, 2014

Euro-Med Laboratories Phil. Inc. declared cash dividend of PHP 0.05 per share to be taken from the unrestricted retained earnings of the corporation as of 31 December 2013, to all stockholders of record as of June 19, 2014 and payable on July 11, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EURO:PM $1.34 PHP 0.00

EURO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EURO.
View Industry Companies
 

Industry Analysis

EURO

Industry Average

Valuation EURO Industry Range
Price/Earnings 28.7x
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow 28.7x
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EURO-MED LABORATORIES PHIL, please visit www.euromedlab.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.